The FDA has granted approval to Eli Lilly and Company’s drug Jaypirca, a therapy to treat chronic lymphocytic leukemia or small lymphocytic lymphoma.
Read the full post on Becker's Hospital Review - Healthcare News
Eli Lilly drug gets new approval for blood cancer
